P419: IDENTIFICATION OF NOVEL THERAPEUTIC OPTIONS FOR VENETOCLAX-RESISTANT AML CELLS THROUGH DRUG REPURPOSING

• A. Ladungova,
• D. Busa,
• Y. Lodhi,
• J. Hyl,
• M. Culen,
• M. Smida

Affiliations

A. Ladungova

1 Central European Institute of Technology, Masaryk University

D. Busa

3 Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University

Y. Lodhi

1 Central European Institute of Technology, Masaryk University

J. Hyl

3 Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University

M. Culen

3 Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University

M. Smida

1 Central European Institute of Technology, Masaryk University